Steve Usdin
Washington Editor at BioCentury focused on U.S. regulatory and policy issues; discussed the FDA commissioner’s national priority review vouchers and agency staffing.
Best podcasts with Steve Usdin
Ranked by the Snipd community
Aug 26, 2025 • 24min
Ep. 317 - Biotech IPOs, FDA-Stealth & Patent Threat
Steve Usdin, the Washington editor, dives into the rare IPO filing by LB Pharma on NASDAQ, amidst a quiet biotech market. He discusses the surge of interest in Hong Kong's biotech scene, contrasting it with challenges faced in the U.S. The podcast explores the FDA's surprising reversal on Stealth BioTherapeutics' Barth syndrome treatment, emphasizing the need for innovation. Usdin also highlights the growing threats to U.S. biopharma innovation posed by potential clashes over intellectual property and regulatory practices.
Sep 6, 2025 • 39min
Ep. 92 - Reimagining FDA: Steve Usdin on Designing the Drug Regulator of the Future
In this engaging conversation, Steve Usdin, Washington Editor at BioCentury with over twenty years of experience in FDA reporting, explores the future of drug regulation. He discusses ideas for restructuring the FDA, including a dedicated agency model and independent oversight. Usdin highlights the Oncology Center of Excellence as a potential blueprint for innovation. He also advocates for learning-driven approaches to regulatory failures and new funding alternatives to restore public trust in the system.
